Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection

Adjuvant chemotherapy after surgery is the standard treatment modality for stage III and part of stage II or stage IV colorectal cancer (CRC) patients. However, the 5-year overall survival (OS) rate remains unsatisfactory. Thus, developing combination therapies is essential to improve the prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qiu-Zhong, Zhao, Jing-Jing, Yang, Chao-Pin, Zhou, Yu-Qing, Lin, Jun-Zhong, Tang, Yan, Gu, Jia-Mei, Wang, Qi-Jing, Li, Yong-Qiang, He, Jia, Chen, Shi-Ping, Song, Meng-Jia, Huang, Yue, Yang, Jie-Ying, Weng, De-Sheng, Xia, Jian-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185208/
https://www.ncbi.nlm.nih.gov/pubmed/32363125
http://dx.doi.org/10.1080/2162402X.2020.1752563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185208/
https://www.ncbi.nlm.nih.gov/pubmed/32363125
http://dx.doi.org/10.1080/2162402X.2020.1752563

Ejemplares similares